A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Public ClinicalTrials.gov record NCT01513863. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multi-Site Clinical Study to Compare the Bioequivalence of Two Metronidazole 1% Topical Gel Formulations in Patients With Moderate to Severe Rosacea
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to demonstrate that metronidazole 1% topical gel is effective for the treatment of patients with moderate to severe rosacea.
Study identification
- NCT ID
- NCT01513863
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 602 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2011
- Primary completion
- May 31, 2012
- Completion
- Aug 31, 2012
- Last update posted
- Dec 22, 2013
2011 – 2012
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator Site | Phoenix | Arizona | — | — |
| Investigator Site | Long Beach | California | — | — |
| Investigator Site | Newport Beach | California | — | — |
| Investigator Site | Denver | Colorado | — | — |
| Investigator Site | Jacksonville | Florida | — | — |
| Investigator Site | Miami | Florida | — | — |
| Investigator Site | Miramar | Florida | — | — |
| Investigator Site | Arlington Heights | Illinois | — | — |
| Investigator Site | Plainfield | Indiana | — | — |
| Investigator Site | Henderson | Nevada | — | — |
| Investigator Site | Hickory | North Carolina | — | — |
| Investigator Site | High Point | North Carolina | — | — |
| Investigator Site | Wilmington | North Carolina | — | — |
| Investigator Site | South Euclid | Ohio | — | — |
| Investigator Site | Hazleton | Pennsylvania | — | — |
| Investigator Site | Simpsonville | South Carolina | — | — |
| Investigator Site | Kingsport | Tennessee | — | — |
| Investigator Site | Knoxville | Tennessee | — | — |
| Investigator Site | Nashville | Tennessee | — | — |
| Investigator Site | San Antonio | Texas | — | — |
| Investigator Site | Webster | Texas | — | — |
| Investigator Site | West Jordan | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01513863, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2013 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01513863 live on ClinicalTrials.gov.